Dr. Reddy’s Laboratories (NYSE: RDY) adds independent director and appoints Deloitte
Rhea-AI Filing Summary
Dr. Reddy’s Laboratories Limited reports that shareholders at the 42nd Annual General Meeting approved several governance resolutions. Dr. K P Krishnan was re-appointed as an Independent Director for a second five-year term from January 7, 2027 to January 6, 2032, not liable to retire by rotation.
Shareholders also approved the appointment of Mr. Srikanth Velamakanni as an Independent Director for five years from July 1, 2026 to June 30, 2031, also not liable to retire by rotation. Both directors are stated to be unrelated to existing directors and not debarred under SEBI or other authorities, and they meet applicable independence criteria.
In addition, M/s Deloitte Haskins & Sells LLP was appointed as Statutory Auditors for five consecutive years, from the conclusion of the 42nd AGM until the conclusion of the 47th AGM.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Independent Director regulatory
Statutory Auditors regulatory
SEBI Listing Regulations regulatory
Annual General Meeting regulatory
DIN regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What is the new term for Independent Director Dr. K P Krishnan at RDY?
When does Mr. Srikanth Velamakanni’s Independent Director term at RDY run?
Who was appointed as Statutory Auditors of Dr. Reddy’s Laboratories (RDY)?
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
July 2026
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.
EXHIBITS
|
Exhibit Number |
Description of Exhibits | |
| 99.1 | Intimation dated July 23, 2026 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
DR. REDDY’S LABORATORIES LIMITED (Registrant) | |||
| Date: July 23, 2026 | By: | /s/ K Randhir Singh | |
| Name: | K Randhir Singh | ||
| Title: | Company Secretary | ||
| 3 |
Exhibit 99.1
 |
Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com |
July 23, 2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited. (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
| Sub: | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations Regulations’) |
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI Listing Regulations and in furtherance to our intimation dated May 12, 2026, we hereby inform that, the members of the Company at the 42nd Annual General Meeting (‘AGM’) held today, have approved the following resolutions with requisite majority:
| 1. | Re-appointment of Dr. K P Krishnan (DIN: 01099097) as an Independent Director |
Approved re-appointment of Dr. K P Krishnan (DIN: 01099097) as an Independent Director for a second term of five consecutive years from January 7, 2027 to January 6, 2032, not liable to retire by rotation.
Dr. Krishnan is not related to any of the Directors or Key Managerial Personnel of the Company and is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority. He meets the criteria for being re-appointed as an Independent Director under the applicable laws.
| 2. | Appointment of Mr. Srikanth Velamakanni (DIN: 01722758) as an Independent Director |
Approved appointment of Mr. Srikanth Velamakanni (DIN: 01722758) as an Independent Director, for a term of five consecutive years, from July 1, 2026 to June 30, 2031, not liable to retire by rotation.
Mr. Srikanth is not related to any of the Directors or Key Managerial Personnel of the Company and is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority. He meets the criteria for being appointed as an Independent Director under the applicable laws.
| 3. | Appointment of M/s Deloitte Haskins & Sells, LLP, Chartered Accountants as Statutory Auditors |
Approved appointment of M/s Deloitte Haskins & Sells, LLP, Chartered Accountants (Firm Registration No. 117366W/W-100018), as the Statutory Auditors of the Company, for a term of five consecutive years, commencing from the conclusion of the 42nd AGM till the conclusion of the 47th AGM.
The disclosures required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are attached as Annexures.
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR
Encl: as above
Details of Dr. K P Krishnan (DIN: 01099097)
| Sl.no. | Particulars | Details |
| 1. | Reason
for change viz. |
Re-appointment |
| 2. | Date
of |
Re-appointment of Dr. K P Krishnan (DIN: 01099097) as an Independent Director of the Company for a second term of five consecutive years from January 7, 2027 to January 6, 2032, not liable to retire by rotation. |
| 3. | Disclosure of relationships between directors (in case of appointment of a director) | Dr. K P Krishnan is not related to any of the Directors of the Company |
Brief Profile of Dr. Krishnan:
Dr. K.P. Krishnan is a former IAS officer with 37 years of distinguished service in public policy, economic governance, and regulatory reform across the Government of India, Government of Karnataka, and the World Bank. He has held key national leadership roles, including Secretary, Ministry of Skill Development and Entrepreneurship; Additional/Special Secretary in the Ministries of Finance and Rural Development; and Secretary to the Prime Minister’s Economic Advisory Council.
A respected academician, he has taught at IIM Bangalore, ISB, and Ashoka University, held the Bok Visiting Professorship at the University of Pennsylvania Law School, and served as IEPF Chair Professor at NCAER, New Delhi. He is currently a Distinguished Fellow at the Isaac Centre for Public Policy, Ashoka University.
Dr. Krishnan serves on the boards and advisory councils of several leading corporates and non-profits, including Dr. Reddy’s Laboratories, Tata Consumer Products, Shriram Capital, ASREC India, Helios Trustee, Razorpay, and the Sanmar Group. He holds degrees in Economics (St. Stephen’s College), Law (Campus Law Centre, University of Delhi), and a Ph.D. in Economics (IIM Bangalore).
Details of Mr. Srikanth Velamakanni (DIN: 01722758)
| Sl.no. | Particulars | Details |
| 1. | Reason
for change viz. appointment, |
Appointment |
| 2. | Date
of appointment/ |
Appointment of Mr. Srikanth Velamakanni (DIN: 01722758) as an Independent Director for a term of five consecutive years, effective from July 1, 2026 to June 30, 2031. |
| 3. | Disclosure of relationships between directors (in case of appointment of a director) | Mr. Srikanth Velamakanni is not related to any of the Directors of the Company |
Brief Profile: Mr. Srikanth Velamakanni
Mr.
Srikanth Velamakanni is one of India’s most influential technology leaders and a global champion of artificial intelligence. He
is the Co-Founder and Group Chief Executive of Fractal, India’s first publicly listed pure-play AI company. He also serves as the
Chairperson of Nasscom and as a Founder-Trustee of Plaksha University. Srikanth’s work is guided by a long-term commitment to building
technology that expands human potential.
Details of Statutory Auditors
| Sl.no. | Particulars | Details |
| 1. | reason
for change viz. appointment, re-appointment, |
Appointment |
| 2. | Date
of appointment/ |
Appointment of M/s Deloitte Haskins & Sells, LLP, Chartered Accountants (Firm Registration No. 117366W/W-100018), as the Statutory Auditors of the Company, for a term of five consecutive years, commencing from the conclusion of the 42nd Annual General Meeting (AGM) till the conclusion of the 47th AGM. |
| 3. | Brief profile (in case of appointment) | Deloitte Haskins & Sells, Mumbai was constituted in 1997 and has been converted to a Limited Liability Partnership (LLP), with the name Deloitte Haskins & Sells LLP (““DHS LLP”” or ““Firm””), w.e.f. November 20, 2013. DHS LLP is registered with the Institute of Chartered Accountants of India (Registration No. 117366W/W-100018) and is a part of Deloitte Haskins & Sells & Affiliates being the Network of Firms registered with the ICAI. The registered office of the Firm is One International Center, Tower 3, 31st Floor, Senapati Bapat Marg, Elphinstone Road (West), Mumbai - 400013, Maharashtra, India. |
| 4. | Disclosure of relationships between directors (in case of appointment of a director) | Not applicable
|